Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:19 PM
Ignite Modification Date:
2025-12-24 @ 11:19 PM
NCT ID:
NCT03129256
Eligibility Criteria:
Inclusion Criteria:
* Pathologically confirmed Non-small cell lung cancer
* Patients with extracranial measurable lesions
* Patients with NSCLC failed for standard treatments
* Eastern Cooperative Oncology Group performance status score: 0\~2 and life expectancy of more than 3 months
* Major organs functioning properly
* Compliance is good and agreed to cooperate with the survival of follow-up
* Informed consent
Exclusion Criteria:
* Contraindications for investigational agents
* Patients with clinical symptoms of brain metastases or meningeal metastasis
* Tumor invade big vessels or close to big vessels
* Uncontrolled hypertension
* Abnormal coagulation (INR\>1.5 or Prothrombin Time\>ULN+4, or Activated Partial Thromboplastin Time\>1.5 ULN), bleeding tendency or receiving coagulation therapy
* Hemoptysis, more than 2.5ml daily
* Thrombosis in 12 months, including pulmonary thrombosis, stoke, or deep venous thrombosis.
* Myocardial ischemia or infarction more than stage II, cardiac insufficiency.
* Received big surgery, had bone fracture or ulcer in 4 weeks.
* Urine protein≥++, or urine protein in 24 hours≥1.0g
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT03129256
Study Brief:
Protocol Section:
NCT03129256